期刊文献+

老年复发卵巢癌患者预后影响因素的多元Logistic回归分析 被引量:4

The multivariate logistic regression analysis of prognostic factors for elderly patients with recurrent ovarian cancer
下载PDF
导出
摘要 目的探讨影响老年卵巢癌患者复发的危险因素。方法分析经病理组织学确诊的137例老年卵巢癌患者的临床资料,其中复发33例。对可能影响复发的8个因素包括肿瘤分期、病理类型、组织分级、术中是否清扫淋巴结、化疗方案、化疗周期、初次治疗后无瘤生存时间和术后是否有肉眼可见残瘤进行单因素分析及多元logistic回归分析,探讨老年卵巢癌患者复发的影响因素。结果单因素分析及多元logistic回归分析均显示肿瘤分期(OR=3.463,95%CI=l_167~10.276)、组织分级(OR=4.627,95%CI=1.367~15.66)和有肉眼可见残瘤(OR=6.679,95%CJ=1.700~26.235)对老年卵巢癌患者的复发有显著影响。结论肿瘤分期、组织类型、有肉眼可见残瘤是老年卵巢癌患者复发的重要影响因素。 Objective To explore the impact of risk factors of the recurrence of senile patients with ovarian cancer. Methods A retrospective analysis of 137 cases of ovarian cancer in elderly patients. The recurrence in 33 cases and non- recurrence in 104 cases were taken. The factor that might influence the recurrence, including tumor stage, pathological type, histological type, intraoperative lymph node dissection, chemotherapy, chemotherapy cycle, after initial treatment, tumor free survival time and postoperative macroscopic residual tumor, were studied by single factor analysis and multivariate logistic regression analysis to find out the influence factors for the recurrence of senile patients with ovarian cancer. Results Single factor analysis and multivariate logistic regression analysis showed that tumor stage (OR=3. 463, 95%Cl=1.167~10.276); tissue type (OR= 4. 627, 95%Cl=1. 367~15. 66) and macroscopic residual tumor (OR= 6. 679, 95%C1=1. 700~26. 235) had a significant impact on elderly patients with recurrent ovarian cancer. Conclusion Tumor stage, histological type, macroscopic residual tumor were the factors that affect the recurrence of elderly patients with ovarian cancer.
出处 《西部医学》 2014年第9期1167-1169,共3页 Medical Journal of West China
关键词 卵巢癌 老年 预后影响因素 Ovarian cancer Aged prognostic factors
  • 相关文献

参考文献15

  • 1朱滔,倪镌,楼寒梅.老年复发卵巢癌患者预后影响因素的临床分析[J].中国癌症杂志,2011,21(2):130-133. 被引量:19
  • 2du Bois A, Reuss A, Pujade - Lauraine E, etal. Role of surgi- cal outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively ran- domized phase 3 multicenter trials [J]. Cancer, 2009, 115(6): 1234-1244. 被引量:1
  • 3舒畅,方艳秋,徐鹏,张晓霞,许淑芬,齐亚灵,刘磊,谭岩.老年上皮性卵巢癌组织中磷酸化AKT和P-gp表达与化疗反应及预后的关系[J].中国老年学杂志,2009,29(6):706-709. 被引量:2
  • 4Janssen-Heijnen M L G, Gondos A, Bray F, etal. Clinical rele- vance of conditional survival of cancer patients in Europe: age- specific analyses of 13 cancers [J]. Journal of Clinical Oncology, 2010, 28(15): 2520-2528. 被引量:1
  • 5高鸿.妇科肿瘤患者生活质量研究[J].中国肿瘤临床与康复,2011,18(3):287-288. 被引量:15
  • 6Mackay H J, Brady M F, Oza A M, etal. Prognostic relevance of uncommon ovarian histology in women with stage Ⅲ/Ⅳ epi- thelial ovarian cancer [J]. International journal of gynecological cancer, 2010, 20(6): 945-952. 被引量:1
  • 7王敏珍,胡晓斌,郑山,寇嘉宁,卢永吉,张荣强,万杏花,李晓凤,杨丽萍,白亚娜.老年妇女生殖系统常见恶性肿瘤直接医疗费用分析[J].中国老年学杂志,2010,30(23):3551-3553. 被引量:13
  • 8Jorgensen T L, Teiblum S, Paludan M, et al. Significance of age and comorbidity on treatment modality, treatment adher- ence, and prognosis in elderly ovarian cancer patients I-J]. Gy- necologic oncology, 2012, 2(14) : 74-79. 被引量:1
  • 9王志梅,张凡,张九鸿,等.老年卵巢癌MGMT,GST-Ⅱ,HIF-1⒈表达与临床预后关系的组织芯片研究[J].中国美容医学,2011,20(4):314-319. 被引量:1
  • 10Jorgensen T L, Teiblum S, Paludan M et al. Significance of age and eomorbidity on treatment modality, treatment adher- ence, and prognosis in elderly ovarian cancer patients [J]. Gy- necologic oneology, 2012, 25(3) 322-328. 被引量:1

二级参考文献68

共引文献58

同被引文献37

  • 1代聪伟,阴梅云.紫杉醇多药联合治疗晚期卵巢癌[J].国际肿瘤学杂志,2006,33(6):456-459. 被引量:4
  • 2苗卉.上皮性卵巢癌Survivin蛋白的表达及拓扑替康对其表达的影响[J].国际肿瘤学杂志,2006,33(12):945-947. 被引量:4
  • 3Siegel R, Ward E, Brawley O, et al. Cancer statistics, 2011 : the impact of eliminating socioeconomic and racial disparities on pre-mature cancer deaths[J]. CA Cancer J Clin, 2011,61 (4) :212- 236. 被引量:1
  • 4Jemal A, Bray F, Center MM, et al. Global cancer statistics[ J]. CA Cancer J Clin, 2011,61 (2) :69-90. 被引量:1
  • 5Su Z, Graybill WS, Zhu Y. Detection and monitoring of ovarian cancer[J]. Clin Chim Acta, 2013,415:341-345. 被引量:1
  • 6Rosen DG, Wang L, Atkinson AJ, et al. Potential markers that complement expression of CA125 in epithelial ovarian cancer[ J]. Gynecol Oncol, 2005,99 ( 2 ) :267 -277. 被引量:1
  • 7Lenhard M, Tsvilina A, Schumacher L, et al. Human chorionic gonadotropin and its relation to grade, stage and patient survival in ovarian cancer[ J]. BMC Cancer, 2012,12 ( 1 ) : 1-8. 被引量:1
  • 8Oberaigner W, Minicozzi P, Bielska-Lasota M, et al. Survival for ovarian cancer in Europe: the across-country variation did not shrink in the past decade[ J]. Acta oncol, 2012,51 (4) :441-453. 被引量:1
  • 9Moore RG, Mlrc Jr. Current state of biomarker development for clinical application in epithelial ovarian cancer [ J ]. Gynecol, 2010,116(2) :240-245. 被引量:1
  • 10Schummer M, Ng WV, Bumgarner RE, et al. Comparative hybrid- ization of an array of 21,500 ovarian cDNAs for the discovery of genes over-expressed in ovarian carcinomas[ J]. Gene, 1999,238 (2) :375-385. 被引量:1

引证文献4

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部